knowledge -WSS

knowledge

author：leisure time 2025-09-27 23:03:50 - browse：6958

Pfizer and Moderna aren’t the only vaccine money-makers. Much of the revenue and profits from Covid-19 vaccines are flowing behind the scenes, going to the contract manufacturers and clinical-trial organizers that turn the shots from lab-bench theory to mass-produced reality.

Both AstraZeneca and Johnson & Johnson publicly committed to not profiting off their products during the pandemic — though AstraZeneca has reserved the right to declare the pandemic over on July 1, even if the World Health Organization has not. Pfizer and Moderna made no such pledge, with Pfizer expected to make $15 billion in vaccine-related revenue this year, while Moderna is forecasting $18.4 billion in vaccine sales.

Contractors hired to test and manufacture these vaccines have enjoyed a share of the profits without the same level of public scrutiny.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Novavax promises a turnaround & Lilly roils the obesity market
Next article： US judge blocks portions of new Florida elections law

focus

WSS

Boston's new lab space is opening empty

Amylyx ALS drug fails trial: Relyvrio patients react with fear, worry

Why depression after traumatic brain injury is distinct

July 4th fireworks can be stressful for dogs. These 6 tips can keep them calm and safe

Michigan man accused of striking an officer during the US Capitol attack is arrested in Florida

Kremlin open to talks over potential prisoner swap involving detained US reporter Evan Gershkovich

hotspot

knowledge

explore

BioMarin wins approval for gene therapy to treat hemophilia A

Male and female sex labels in research insufficient, scientists say

Duchenne breakthrough therapy leaves behind pioneering families

As AI in medicine takes off, can 'human in the loop' prevent harm?

Hepatitis C has a cure — but many Americans still lack access to it

Readout Newsletter: Bristol, Sangamo, Gilead, and more

Hollywood unions extend contract negotiations for actors

EPA limits use of carcinogenic gas for sterilizing medical devices

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Bayer exec: U.S. is key in reviving beleaguered pharma’s drug pipeline

hotspot

Kremlin open to talks over potential prisoner swap involving detained US reporter Evan Gershkovich

EPA limits use of carcinogenic gas for sterilizing medical devices

The Democratic Party promised to overhaul its primaries. Doing that has been anything but simple

Elon Musk announces 'temporary limits' for reading Twitter posts

Ebola: Gilead Sciences antiviral shows promise as new treatment

FDA advisers back CAR

hotspot

Wikipedia

focus

entertainment